Publication | Closed Access

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

Mitomycin CMedicinePathologyBronchial NeoplasmStage IiibSurvival AdvantageAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerCancer Research